The aminobisphosphonate risedronate preserves localized mineral and material properties of bone in the presence of glucocorticoids.
about
Multiscale alterations in bone matrix quality increased fragility in steroid induced osteoporosisEffect of sequential treatments with alendronate, parathyroid hormone (1-34) and raloxifene on cortical bone mass and strength in ovariectomized rats.Prevention of glucocorticoid induced bone changes with beta-ecdysone.Prolonged treatments with antiresorptive agents and PTH have different effects on bone strength and the degree of mineralization in old estrogen-deficient osteoporotic rats.Prednisolone treatment and restricted physical activity further compromise bone of mdx mice.Glucocorticoid-induced bone loss in mice can be reversed by the actions of parathyroid hormone and risedronate on different pathways for bone formation and mineralizationShort-courses of dexamethasone abolish bisphosphonate-induced reductions in bone toughness.Sclerostin-antibody treatment of glucocorticoid-induced osteoporosis maintained bone mass and strength.Comparison of the effect of vitamin K(2) and risedronate on trabecular bone in glucocorticoid-treated rats: a bone histomorphometry studyMeasurement of the toughness of bone: a tutorial with special reference to small animal studies.Prolonged alendronate treatment prevents the decline in serum TGF-β1 levels and reduces cortical bone strength in long-term estrogen deficiency rat modelStrain dependent differences in glucocorticoid-induced bone loss between C57BL/6J and CD-1 mice.Improved Mobilization of Exogenous Mesenchymal Stem Cells to Bone for Fracture Healing and Sex Difference.Glucocorticoids cause mandibular bone fragility and suppress osteocyte perilacunar-canalicular remodelingOptical Biosensor Based on Microbendings Technique: An Optimized Mean to Measure the Bone Strength
P2860
Q27324822-864D3ECC-2865-4FE5-A588-07388A8F0E17Q34149279-2BFF1D1F-AA0B-40E9-91C8-52BBDC70DAB6Q35163490-69C8954D-C5E1-4848-8590-80CF63182D59Q35747404-494CB2BF-D90E-4593-BA25-C773B2B85F4EQ36006306-AAE14861-AA50-49B4-9D9A-E9E61C5D771AQ37003240-65F8C64C-5FEF-4FFA-B8F9-CC97C2254241Q37067163-A7D9C96F-04BD-4C55-88AF-C66E92B10764Q37119856-CCC9E05D-B2A9-4203-898E-535490FC4D25Q37183254-02586681-86B3-47C1-8F01-79A77AC124D5Q37223996-FCA5FFD2-1E30-4AD2-8739-9A6AEA3F7B5DQ37244297-206B0718-722F-4A42-A072-CA4A242C7DE6Q37415046-06903F27-9458-4C17-94E8-4732E9F182C0Q46898799-D2F2622C-E705-434E-95A1-2E6EE390064DQ57298071-C6A22651-1E07-4F60-8A46-9458883F28A9Q59048094-77479EFE-5AAB-46ED-B41F-ACF3D2F1F5B9
P2860
The aminobisphosphonate risedronate preserves localized mineral and material properties of bone in the presence of glucocorticoids.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
The aminobisphosphonate risedr ...... e presence of glucocorticoids.
@en
The aminobisphosphonate risedr ...... e presence of glucocorticoids.
@nl
type
label
The aminobisphosphonate risedr ...... e presence of glucocorticoids.
@en
The aminobisphosphonate risedr ...... e presence of glucocorticoids.
@nl
prefLabel
The aminobisphosphonate risedr ...... e presence of glucocorticoids.
@en
The aminobisphosphonate risedr ...... e presence of glucocorticoids.
@nl
P2093
P2860
P356
P1476
The aminobisphosphonate risedr ...... he presence of glucocorticoids
@en
P2093
Alexandra E Porter
Guive Balooch
Mehdi Balooch
Nancy E Lane
Ravi K Nalla
Robert O Ritchie
P2860
P304
P356
10.1002/ART.22976
P50
P577
2007-11-01T00:00:00Z